Clinical Trials

NCT IdNCT04107896
TitleEfficacy of Silodosin in the Treatment of Symptomatic Benign Prostatic Hyperplasia (BPH)
ConditionBenign Prostatic Hyperplasia
StudyTypeInterventional
OrganizationBangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
Sponsor/CollaboratorsBangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
StatusCompleted
GenderMale
AgeGroupAdult
Older Adult
Location (with distance)
  • Maidul islam, Dhaka, Bangladesh
DescriptionIn this study the investigators had evaluated the effectiveness SILODOSIN (8 mg daily orally) in Benign prostatic Hyperplasia in comparison to Tamsulosin (0.4 mg daily orally) in a randomized controlled trial design. Study population would be patients attending Urology OPD of BSMMU Hospital, Dhaka. Target sample size will be 136 evaluable patients in each group (assuming dropout rate 20%), suffering from Benign prostatic Hyperplasia .Subjects would be observed for 1 week without any drug. At the end of 1 week, they would be randomly allocated to Silodosin or Tamsulosin and treatment continued for 12 weeks. Interim follow-up visits would be at 1,4 and 12 weeks. USG confirmation of BPH would be required for recruitment. Effectiveness of the drugs would be assessed by International Prostate Symptom score, a quality of life (QoL) assessment done by a 7-point scale. Prostate weight/volume determination by USG, Change in post voidal residual urine (PVR) by USG and Changes in peak urine flow rate by uroflowmetry. Safety would be assessed by following up vital signs, treatment emergent adverse events and routine laboratory tests for drug safety.